Explore Our Investment Universe

The life sciences and biotechnology sectors represent a convergence of scientific progress and significant unmet medical need, creating investment opportunities of exceptional magnitude. At XGEN VENTURE SGR SPA, we systematically map the innovation landscape to identify companies with the potential to redefine standards of care. Our investment universe spans drug discovery, biologics, diagnostics, medical devices, digital health, and adjacent enabling technologies. We apply a thematic lens to portfolio construction, ensuring exposure to the trends most likely to drive value over the coming decade. From genomic medicine to AI-driven drug design, our deal flow reflects the full breadth of modern life sciences innovation. Exploring this universe requires scientific literacy, market insight, and global network — capabilities that define the XGEN VENTURE team.